Tag Archives: reference regulation

Cross-sectoral Standard Provisions for Regulation

This document contains mostly very general provisions. It is intended as a source of inspiration for those drafting laws and other forms of regulation in any regulatory or policy area. Readers are invited to select provisions that they consider useful for their specific regulatory or legislative task and to adapt them to their specific needs. No provision should be taken without considering the need for adaptation. Continue reading Cross-sectoral Standard Provisions for Regulation →

Report on Artificial Intelligence: Part II – outline of future regulation of AI

This Part II of the howtoregulate Report on Artificial Intelligence presents regulatory approaches for minimizing the harms of artificial intelligence (AI), evidently without putting into question the utility of AI. What should regulation of Artificial Intelligence look like? The answer to this question depends on the goals of the regulator. As was previously outlined in Part I, much of the goals of states today is to focus on incentivizing innovative applications of AI or encouraging breakthrough AI research. We could imagine, however, that the average regulator might also consider such goals as avoiding the risk that AI research or technology leads to the eradication of humankind and reducing other major risks for human beings to the extent that the expected positive effect of AI is not disproportionately hampered. Furthermore, regulators might feel compelled to deal with particular risks linked to specific technological uses. Continue reading Report on Artificial Intelligence: Part II – outline of future regulation of AI →

Reference legislation on medicines

Regulators who wish to develop or amend regulation for their respective jurisdiction might wish not to start from scratch, but to learn from other jurisdictions. Therefore we present here some legislation on medicines / pharmaceuticals / drugs of different jurisdictions as models. The models have different degrees of complexity. We start with rather simple models and go up to the quite complex models. Continue reading Reference legislation on medicines →